<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="132717">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01788878</url>
  </required_header>
  <id_info>
    <org_study_id>CARDEL-1211</org_study_id>
    <nct_id>NCT01788878</nct_id>
  </id_info>
  <brief_title>Cancer of the Upper Aero-digestive Tract and Future Socioprofessional</brief_title>
  <acronym>CARDEL</acronym>
  <official_title>Cancer of the Upper Aero-digestive Tract and Future Socioprofessional</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Oscar Lambret</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Oscar Lambret</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <authority>France: Committee for the Protection of Personnes</authority>
    <authority>France: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé</authority>
    <authority>France: The Commission nationale de l’informatique et des libertés</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Socio-professional data collection, medical, psychological, demographic, economic, and
      educational to patients within the care pathway  for cancer of the upper aero-digestive
      tract.

      A series of questionnaires will be presented at the initial consultation and then 6 months,
      12 months and 18 months during follow-up visits. Medical data will be collected via the CRF.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Identify the main  psycho-medical and socio-professional determinants associated with return to work versus non return to work for patients with head and neck cancer</measure>
    <time_frame>At month 18</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Identify methods of returning to work.</measure>
    <time_frame>At month 6, month 12, month 18</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Identify alternatives to return to work or suffered chosen (retirement, disability, etc ...) •</measure>
    <time_frame>At month 6, month 12, month 18</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Identify psychological factors that might interfere with the behavior to return to work (attitudes deal with problems, anxiety, depression)</measure>
    <time_frame>At baseline, Month 6, Month 12, Month 18</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Different information collected in the questionnaire perceived support</measure>
    <time_frame>At baseline, Month 6, Month 12, Month 18</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>Questionnaires</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Questionnaires</intervention_name>
    <arm_group_label>Questionnaires</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age at diagnosis ≥ 18 to ≤ 55 years

          -  Employed at the time of entry into the care pathway

          -  Presenting a head and neck cancer (excluding nasal), stage I, II and III, under a
             first anti-tumor treatment (surgery, radiotherapy, or chemotherapy)

          -  Patient mastering the French language

          -  Affiliated with social security

          -  Consent signed by the patient before the implementation of any specific procedure to
             studyAnnuler les modificationsAlpha

        Exclusion Criteria:

          -  Having been treated for another cancer before (except skin cancer and / or prostate)

          -  Metastatic disease immediately

          -  Patients unable to undergo regular monitoring

          -  Presenting psychiatric
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sophie FANTONI, Pr</last_name>
    <phone>+33(0)3 20 44 57 94</phone>
    <email>fanquin@wanadoo.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire</name>
      <address>
        <city>Caen</city>
        <zip>14 033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Emmanuel BABIN, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vincent PATRON, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marjorie LOAEC, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aurélien MEUNIER, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Oscar Lambret</name>
      <address>
        <city>Lille</city>
        <zip>59020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dune Lemettre, CRA</last_name>
      <phone>33 20 29 59 35</phone>
      <email>d-lemettre@o-lambret.fr</email>
    </contact>
    <investigator>
      <last_name>Morbize JULIERON, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHR-U</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Timone</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Nicolas FAKHRY, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antoine GIOVANNI, Pr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier universitaire</name>
      <address>
        <city>Rouen</city>
        <zip>760310</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Olivier CHOUSSY, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexandre PAVIOT, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas BON-MARDION, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>March 6, 2014</lastchanged_date>
  <firstreceived_date>January 31, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
